Precision medicine in breast cancer: reality or utopia?

Abstract : Many cancers, including breast cancer, have demonstrated prognosis and support advantages thanks to the discovery of targeted therapies. The advent of these new approaches marked the rise of precision medicine, which leads to improve the diagnosis, prognosis and treatment of cancer. Precision medicine takes into account the molecular and biological specificities of the patient and their tumors that will influence the treatment determined by physicians. This new era of medicine is accessible through molecular genetics platforms, the development of high-speed sequencers and means of analysis of these data. Despite the spectacular results in the treatment of cancers including breast cancer, described in this review, not all patients however can benefit from this new strategy. This seems to be related to the many genetic mutations, which may be different from one patient to another or within the same patient. It comes to give new impetus to the research-both from a technological and biological point of view-to make the hope of precision medicine accessible to all.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01578934
Contributeur : Liic - Université de Bourgogne <>
Soumis le : mercredi 30 août 2017 - 10:08:11
Dernière modification le : mercredi 5 septembre 2018 - 17:04:05

Lien texte intégral

Identifiants

Collections

Citation

Ali Bettaieb, Catherine Paul, Stéphanie Plenchette, Jingxuan Shan, Lotfi Chouchane, et al.. Precision medicine in breast cancer: reality or utopia?. Journal of Translational Medicine, BioMed Central, 2017, 15 (1), pp.139. 〈https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1239-z〉. 〈10.1186/s12967-017-1239-z〉. 〈hal-01578934〉

Partager

Métriques

Consultations de la notice

73